Mammoth Biosciences partners with GSK to develop handheld CRISPR-based Covid-19

The full title is "Mammoth Biosciences partners with GSK to develop handheld CRISPR-based Covid-19 test".

However, given the problems with CRISPR potentially causing large numbers of unexpected changes for some gene targets (see links below), the original title of the submission (without the test) may be accurate/prophetic: applying CRISPR to the COVID19 problem could very well make the problem worse by creating a CRISPR version of COVID-19, because we don't know well enough how to control CRISPR results.

[1] https://cen.acs.org/biological-chemistry/biotechnology/CRISP...

[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796662/

[3] https://www.eurekalert.org/pub_releases/2018-07/wtsi-gdf0713...